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Background: Since the first successful synthesis of Ag(I)-N-heterocyclic carbene complex in 1993, this class of
compounds has been extensively used for transmetallation reactions where the direct synthesis using other metal ions
was either difficult or impossible. Initially, silver(I)-NHC complexes were tested for their catalytic potential but could not
get fame because of lower potential compare to other competent compounds in this field; however, these compounds
proved to have vital antimicrobial activities. These encouraging biomedical applications further convinced researchers to
test these compounds against cancer. The current work has been carried out with this aim.
Results: N-ipropylbenzimidazole was synthesized by reaction of benzimidazole with ipropyl bromide. The subsequent
treatment of the resulting N-alkylbenzimidazole with ortho/meta/para-(bromomethylene) benzene afforded
corresponding bis-benzimidazolium bromides (5-7). The counter anion (Br-) of each salt was replaced by
hexaflourophosphate (PF6
- ) for the ease of handling and further purification (8-10). Each salt (Ligand), in halide form,
was further allowed to react with Ag2O with stirring at room temperature for a period of two days to synthesize dinuclear
Ag(I)-NHC complexes (11-13). All synthesized compounds were characterized by spectroscopic techniques and
microanalysis. Molecular structures of compounds 5, 9 & 10 were established through single crystal x-ray diffraction
technique. All the compounds were assessed for their anti-proliferation test on human colorectal cancer cell line
(HCT 116). Results showed that the ligands (5-10) showed mild to negligible cytotoxicity on HCT 116 cells whereas
respective silver complexes (11-13) exhibited dose dependent cytotoxicity towards the colon cancer cells with IC50 ranges
between 9.7 to 44.5 μM. Interestingly, the complex 13 having para-xylyl spacer was found the most active (IC50 9.7 μM)
that verifies our previously reported results.
Conclusions: All the bis-benzimidazolium salts (8-10) were found inactive whereas after bonding with silver cations, the
Ag(I)-NHC complexes (11-13) showed a dose dependent cytotoxic activity. This proved that silver practice an important
role in death of cancer cells. Also, the N-alkyl/aryl substitutions and ortho/metal/para xylyl units regulate the cytotoxicity.* Correspondence: rosenani@usm.my
†Equal contributors
1The School of Chemical Sciences, Universiti Sains Malaysia, 11800 USM,
Penang, Malaysia
Full list of author information is available at the end of the article
© 2013 Iqbal et al.; licensee Chemistry Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Iqbal et al. Chemistry Central Journal 2013, 7:27 Page 2 of 17
http://journal.chemistrycentral.com/content/7/1/27Background
Deaths due to cancer are on increase. According to global
cancer statistics in 2002, there were 10.9 million new can-
cer cases and 6.7 million deaths [1] worldwide, whereas in
2008 this number increased to 12.66 million new cases and
more than 7.5 million deaths. New drugs to fight cancer
are constantly needed.
Different therapeutic options like chemotherapy, radio-
therapy and surgery are now extensively used to treat vari-
ous types of cancer. In chemotherapy, the discovery of
cisplatin by Rosenberg and co-workers is perhaps the first
historical example of anticancer metal-based drugs [2].
However, the severe side effects confined its applications.
Later on, a number of its derivatives were synthesized and
biologically evaluated but only few of them proved to have
pharmacological advantages relative to cisplatin [3,4]. Plat-
inum based drugs are now so frequently used that only
oxaliplatin, a platinum based drug, is expected to cross
2 billion Euros business in the next two years [5]. This
drug was recently approved to be used as a second line
therapy in metastatic colorectal cancer and showed minor
side affects so far which can be treated symptomatically.
In addition to platinum based drugs, a wide range of
transition-metal drugs have been at various stages of de-
velopment [4,6-8], however, none of them could pass all
the stages of clinical development until today [4].
Recently, Metal N-heterocyclic carbene (M-NHC) com-
plexes appeared as an emerging field of research in medi-
cinal chemistry. This is also evident by recent research
reports [9-11] and several reviews [4,12-14]. It is impor-
tant to highlight that a major portion of these findings is
based on imidazole nucleus; however, its benzimidazole
derivative has been rarely explored in organometallic
chemistry [15], especially for biological applications [16];
whereas in organic chemistry a number of its organic deri-
vatives have shown many promising therapeutic activities
including cancer [17,18]. The structural resemblance of
benzimidazole derivatives with the naturally occurring nu-
cleotides allows them to interact with the biopolymers of
the living system and hence, signifies their biological im-
portance [17].
Due to aforementioned reasons, we used this chemical
entity (benzimidazole) to synthesize organometallic com-
pounds to be tested against cancer. However, while deal-
ing with biological systems, the selection of metals is also
an important and judicious issue. Silver salts have historic-
ally been used to maintain human health. Many early civi-
lizations used silver salts for purification of drinking water,
healing wound, and prevention of eye infections in new-
borns [14,19-21]. Worldwide extensive use of silver sul-
fadiazine as a tropical medicament for infected burns
renders a notion on safety of silver salts. Now a days, silver
is also used in consumer products like clothing, antibacte-
rial sprays, cosmetics, cell phones, laptop keyboards,dietary supplements and more [22]. It is however, the low
toxicity of silver salts for humans that has attracted re-
searchers to further explore their biomedical applications,
specifically antimicrobial and anticancer [4,14,20,23,24].
It was certain that the chemical combination of these
biologically important moieties would provide a medi-
cally advanced class of compounds. Interestingly, only
bis-benzimidazolium salts, the precursors to form Ag-
NHC, showed potential anticancer activity [25]. How-
ever, later on we reported that silver in bonding with
these bis-benzimidazolium salts through Ag-NHC route,
enhances the anticancer potential [26-29]. On the other
hand, our published [30] and unpublished data reflects
that imidazole based ligands with similar structure, bis-
imidazolium salts, are either completely inactive or have
mild cytotoxicity against cancer cells. However, the imid-
azole based Ag(I)-NHC complexes were found to have a
diverse anticancer potential.
Inspiring from our previous research on anticancer
potential of benzimidazole based ligands and respective
dinuclear Ag(I)-NHC complexes [26-28], in this research,
N-ipropyl substituted ortho/meta/para xylyl linked bis-
benzimidazolium salts were synthesized either with brom-
ide or hexaflourophosphate counter anions and were
further bonded with silver metal ions in order to test their
potential against cancer cells. Unlike our previous reports
[26-28,31], all the ligands were found inactive but respec-
tive silver complexes showed cytotoxicity in a dose
dependent manner. All of our previous and current results




N-ipropylbenzimidazole was synthesized by a developed
method [32] with minor modifications (see Additional
file 1: Supplementary I). Furthermore the reaction of
two equivalents of N-ipropyl benzimidazole with 1,2/1,3/
1,4-(bromomethylene)benzene in 1,4-dioxane at 80-100°C
for 24 h afforded the product in good yields (Scheme 1).
In the case when product settled as a sticky brownish
fluid at the bottom of flask, the upper layer was decanted
and product was washed with fresh 1,4-dioxane (3 × 5ml).
The resulting bromide salt was converted directly to a
hexaflourophosphate counterpart by metathesis reaction
using KPF6 (2 equivalents) in 50 mL of methanol or H2O/
MeOH system.The mixture was stirred for 3 h and fil-
tered. The white precipitates were collected and washed
with distilled water (2 × 5 mL), then left to dry at ambient
temperature. However, In the case when product appeared
as solid (precipitates) in the reaction medium. The pre-
cipitates were collected, washed with fresh 1,4-dioxane
(3 × 5 mL), dried at RT for 24 h, and ground to fine pow-
der (See Additional file 2: Supplementary II).
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phosphate counter ions were dissolved in acetonitrile
alongwith Ag2O and stirred for a period of 2 days at
room temperature. Reaction mixture was then filtered
by celited 545 to collect a clear solution. In some cases
filtration process had to repeat two to three times to col-
lect a crystal clear solution. So obtained was evaprated
under reduceed pressure to collect powderious material
and recrystalized by acetonitrile/water system. However,
ligands with bromide counter ions were dissolved in
methanol following the same procedure, stopping at till
filtration. So obtained was then converted to hexaflouro-
phophate counter ion by metathesis reaction, according
to which halide salt of compund is stirred at room tem-
perature with potassium hexaflourophosphate salt. White
precipitates are expected within few minute, however
stirring for a period of 3 h is necessary. Precipitates
were filtered by whatman filter paper, washed by water
(3 × 5 mL) following by methanol (3 × 5 mL). In some
cases, white precipitates do not appear and addition of
water is necessary in the metathesis reaction mixture
(See Additional file 3: Supplementary III).
For ligands, conversion of counter anion from halide
to hexaflourophosphate is done only for the ease ofScheme 1 Synthesis of N-ipropyl benzimidazole, Bis-imidazolium saltshandling whereas for complexes this method is the way
to purity if and only if halide salt of ligand is used as
starting material in methanol as describe above.
The PF6 salts of all the compounds are soluble in aceto-
nitrile, DMSO, and DMF but not soluble in methanol,
ethanol, and water whereas the halide salts of ligands and
complexes are soluble in methanol, ethanol, DMSO, DMF
and water except acetonitrile.FT-IR spectra of the compounds
N-alkyl substituted bis-benzimidazolium salts do not
have many functional groups to be characterized by IR
spectroscopic technique. However, it is possible to study
some spectral features of these salts and their respective
metal-complexes as specific patterns can be observed,
which may be used as primary indicators of a successful
synthesis [26].
For the halide salts of ligands (5-7.2Br), strong and
sharp stretching vibrations (3402 – 3424 cm-1) appeared
for tertiary nitrogens of azolium ring (Caliph-Nbenzimi)
which are overlapped by water peak due to the presence
of hydrated water in these compounds (see Figure 1). In
single crystal structures of bis-benzimidazolium halides(5-10), and respective dinuclear Ag(I)-NHC complexes (11-13).
Figure 1 FT-IR overly spectra of bis-benzimidazolium dibromide precursors (5-7. 2Br). The peaks labeled as 3 in the red box indicate the
overlap of tertiary N-atom of benzimidazolium ring by hydrated water molecules.
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(X = Cl/Br) anions through X–H-O hydrogen bondings
[33,34]. This type of overlapping is rare in bis-imidazolium
halides due to absence of hydrated water molecules
[35,36]. Also, the pure modes of these vibrations can be
observed in PF6 salts of these compounds (8-10.2PF6) due
to absence of hydrated water molecules (See Figure 2).
The pure modes of the C-H stretching vibrational bands in
bis-benzimidazolium salts appeared at around 2900 to 3000
cm-1 (C-Haliph). This variation in the range is due to pres-
ence of C-H (sp3-s) stretching of alkyl chains and methy-
lene (N-CH2-Ar) group. A strong and sharp intense band
was observed in the range 1350 to 1500 cm-1 ascribed to
the stretching modes of vibrations of benzimidazole ring
due to the presence of -HC=N- module [37]. It may be



















Figure 2 FT-IR overly spectra of bis-benzimidazolium bis (hexaflourop
3 in the red box represent the pure modes of tertiary N-atom in benzimidabenzimidazolium salts, as compare to N-alkylazole, is prob-
ably caused by the conjugation of C=N bond with the azole
ring and due to N-alkylation, where alkyl group acts as elec-
tron donating entity. The other ring vibrations are intense
bands at around 1050 and 1220 cm-1.
We also found interesting features of FT-IR to confirm
a successful synthesis of Ag-NHC complexes. We
observed that binding of NHC carbon with silver metal
ion strengthens vibrations in the range 1350 – 1500 cm-1
and a characteristic “four fingers (f.fs)” pattern appears for
all the Ag-NHC complexes. This region is specific for –
C=N (Carom-Nbenzimi) ring stretchings. The observed “f.fs”
pattern is entirely different than all the respective
vibrations in azolium salts and is easily distinguishable
(See Figure 3). This is in accordance with our previous








hosphate) precursors (8-10. 2PF6). The weak FT-IR signals labeled as
zolium ring.






























Figure 3 FT-IR overly spectra of Ag(I)-NHC complexes (11-13. 2PF6). The strong intense bands labeled as 1 in solid red box provided the
preliminary confirmation of the formation of Ag(I)-NHC complexes.
Figure 4 1H NMR spectrum (d6-DMSO*/d3-acetonitrile**, 500 MHz) indicating the changes in chemical shifts after successful reaction
between 5 and Ag2O to get dinuclear complex 11. The acidic proton signal Hd disappears on complex formation.
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Figure 5 13C NMR spectra (d6-DMSO/d3-acetonitrile, 125 MHz) indicating the changes in chemical shifts and appearance of two
doublets after successful reaction between 5 and Ag2O to get dinuclear Ag-NHC complex 11.
۩Naturally occurring Silver (Ag) is composed
of the two stable isotops 107Ag and 109Ag with 107Ag being the more abundant (51.84%). J109Ag-C = 208 Hz. J107Ag-C = 184 Hz.
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FT-NMR spectra of all the compounds were analyzed in
d6-DMSO, d3-Acetonitrile, and d4-methanol over the
scan range 0 to 12 δ ppm for 1 H NMR and 0 to 210 δ
ppm for 13 C NMR studies. In the 1H NMR spectra, a
characteristic sharp singlet (Hd) in the range δ 10.00 –
10.30 for benzimidazolium salts for acidic proton (NCHN)
indicated the successful formation of target ligands 5-7 &
8-10, respectively [38,39]. For salts (5-10) the characteris-
tic peaks for benzylic protons (N-CH2-Ar, Hc) and pro-
tons at secondary carbons (N-CH-R2, Hb) appeared in the
range δ 5.81 – 6.40 and 4.52 – 5.20, respectively.
Synthesis of Ag-NHC complexes was confirmed by the
disappearance of acidic proton peak (Hd) (See Figure 4).
The signals caused by benzylic (N-CH2-Ar) group, which
connects xylyl unit with benzimidazolium units, dis-
played sharp singlets in the range δ 5.13 - 5.64 ppm for
silver complexes. These resonance values are compa-
rable with corresponding ligands.Similarly, the structural features of the salts were fur-
ther confirmed by the 13C NMR data. In 13C NMR spec-
tra, the chemical shift values of C4 carbon (NCN) were
observed within the range δ 141 – 143 ppm, which is
also in agreement with reported data for similar azolium
salts [39,40]. Upon complexation with Ag, two doublets
appear at ca. δ 189 for benzimidazole based Ag-NHC
complexes with Ag-C coupling constants ca. 208 Hz and
180 Hz (See Figure 5).
These doublets appear in dimeric complexes of struc-
ture [L2Ag2]
2+ due to carbene carbon bonding to C-Ag107
and C-Ag109, respectively [26,41]. In case of imidazole
based Ag-NHC complexes such doublets appear at
ca. δ180 with splitting patterns 180 – 189 Hz for Ag107
and 204 – 220 Hz for Ag109 [42]. The resonances of aro-
matic carbons were found in the comparable region
around δ 113 – 137 in Ag(I)-NHC complexes (11 – 13.
2PF6). Also, the benzylic carbon (N-C-Ar) and alkyl chain
carbon resonances were observed in the chemical shift
Table 1 Crystal data and structure refinement details for carbene precursor 8, 9, and 10
5 9 10
Formula C28H36N4Br2O2 C28H32 F12N4P2 C28H32 F12N4P2
Formula weight 620.41 714.52 714.52
Crystal system Monoclinic Monoclinic Monoclinic
Space group P-21/c P-21/c P-21/n
Unit cell dimensions
a (Å) 10.3809(2) 16.3719(4) 12.0379(6)
b (Å) 11.7017(3) 10.0392(2) 10.2165(5)
c (Å) 11.3918(2) 19.1499(4) 12.7232(6)
α (o) 90.00 90.00 90.00
β (o) 91.742(1) 96.896(1) 96.236(1)
γ (o) 90.00 90.00 90.00
V (Å3) 1383.17(5) 3124.72(12) 1555.51(13)
Z 2 4 2
Density (calcd) (gm/cm3) 1.490 1.519 1.526
Abs coeff (mm-1) 2.962 0.238 0.239
F(000) 636 1464 732
Crystal size (mm) 0.13 x 0.26 x 0.35 0.23 x 0.27 x 0.39 0.10 x 0.22 x 0.27
Temperature (K) 100 100 100
Radiation (Å) MoKa 0.71073 MoKa 0.71073 MoKa 0.71073
θ Min, max (o) 2.5, 32.7 2.1, 31.9 2.6, 33.3
Dataset −13: 15; -17: 17; -17: 17 −20: 24; -14: 14; -28: 28 −18: 18; -15: 15; -19: 19
Tot.; Uniq. Data 20647 41315 22401
R (int) 0.026 0.033 0.026
Nref, Npar 9569, 329 10750, 419 5971, 208
R, wR2, S 0.0334, 0.0630, 0.93 0.0522, 0.1531, 1.04 0.0370, 0.1134, 1.04
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spectively. These resonance values are δ 2-3 ppm down-
field as compare to corresponding ligands.
Crystallography
The molecular structures of the benzimidazolium salts
Additional files 4, 5, 6: 5, 9, 10 were determined by singleTable 2 Selected bond lengths (Å) and angles (o) of 5
C23-C24 1.506(3) N2-C8 1.461(3) C7-C6 1.394(3)
C23-N1 1.492(2) C8-C9 1.509(3) C2-C7 1.391(3)
N1-C1 1.319(3) C9-C14 1.410(3) C3-C4 1.376(3)
C1-N2 1.343(3) C9-C10 1.392(3) C1-H1 0.9500
N2-C7 1.389(3) C10-C11 1.392(3) O1-H2 (W1) 0.8500
C24-C23-C25 111.71(18) N2-C8-C9 114.61(16)
C24-C23-N1 110.34(16) C8-C9-C14 116.84(16)
N1-C1-N2 110.32(18) C8-C9-C10 123.94(17)
C23-N1-C2 124.97(16)
C1-N2-C8 124.32(18)crystal X-ray diffraction studies. Crystal refinement data,
selected bond lengths and angles of salts Additional files
4, 5, 6: 5, 9, 10 are tabulated in Tables 1,2,3,4.
Salt Additional file 4: 5 crystallizes in monoclinic space
group P21/c with one cationic bis-benzimidazolium core,
two bromide counter anions and two water molecules.
Bromide counter anions and water molecules areTable 3 Selected bond lengths (Å) and angles (o) of 9
C23-C24 1.520(3) N2-C8 1.464(2) C7-C6 1.394(2)
C23-N1 1.486(2) C8-C9 1.515(2) C2-C7 1.395(2)
N1-C1 1.328(2) C9-C14 1.397(2) P1-F1 1.6014(13)
C1-N2 1.332(2) C9-C10 1.392(2) C1-H1 0.9500
N2-C7 1.395(2) C10-C11 1.389(3)
C23-C24-C25 111.84(15) N2-C8-C9 111.92(13)
C24-C23-N1 110.08(14) C8-C9-C14 119.69(14)
N1-C1-N2 110.91(14) C8-C9-C10 120.69(15)
C23-N1-C2 127.10(13)
C1-N2-C8 126.51(13)
Table 4 Selected bond lengths (Å) and angles (o) of 10
C9-C8 1.5201(15) N2-C2 1.3886(13) C2-C3 1.3955(16)
C8-N1 1.4864(12) C11-C12 1.5145(14) C4-C5 1.4020(19)
N1-C1 1.3316(12) C12-C13 1.3957(13) P1-F1 1.5936(9)
C1-N2 1.3349(13) C13-C14 1.3943(14) C1-H1 0.9500
N2-C11 1.4609(13) C7-C6 1.3959(14)
C9-C8-C10 112.29(9) N2-C11-C12 112.69(8)
C9-C8-N1 109.41(8) C11-C12-C13 118.52(8)
N1-C1-N2 110.64(8) N2-C2-C3 131.12(10)
C8-N1-C1 126.89(8)
C1-N2-C11 125.88(8)
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bonding. Bond angles (H-O-H) of one of the water
molecules is 95.75o whereas for the 2nd one it is 104.43o.
This variation in bond angels might be due to strong
and weak interactions of hydrogens with bromide coun-
ter anions (See Figure 6). Crystal studies reveal that both
benzimidazolium cores are almost perpendicular to xylyl
unit making angles of 114.61(16)o and 115.83(16)o facing
opposite directions. Similarly, the terminal ipropyl groups
are also almost perpendicular to the planes of the benzimi-
dazole rings making angles around 108-110o. These ter-
minal ipropyl groups are also facing opposite directions on
both ends of bis-benzimidazolium core with internal ipro-
pyl angles 111.71(18) for C24-C23-C25 and 112.07(18)o
for C27-C26-C28. The internal imidazole ring angle
(N–C–N) at the carbene center is 110.32(18)° for N1-
C1-N2 and 110.30(18)° for N3-C22-N4, and these values
are well within the range for similar benzimidazole based
salts [34,43-45]. In the crystal, the bromide anions link the
cations with a three-dimensional network via the intermo-
lecular hydrogen bonding C-H. . ..Br (2.869 and 2.953 Å)
to benzylic hydrogens (N-CH2-Ar) and acidic proton
(NCHN). Also water molecules are bonded with the benzi-
midazolium core through the intermolecular hydrogen
bonding via H-O. . ..H (2.284 and 2.629 Å) to benzylic
hydrogens (N-CH2-Ar). A perspective view of the salt and
its crystal packing are shown in Figure 7.
Salt Additional file 5: 9 also crystallizes in monoclinic
space group P-21/c with one cationic bis-benzimidazolium
core and two hexaflourophosphate anions. Crystal studies
reveal the existence of salt in a zig-zag manner having ben-
zimidazoles almost perpendicular to the plane of xylyl
group. However, the shape of the entire molecule depends
on the terminal N-alkyl/aryl substituent which readily
offers the rigidity and finite shape. The internal imidazole
ring angle (N–C–N) at the carbene center is 110.75(18)°
for N4-C22-N3 and 110.91(18)° for N1-C1-N2, and these
values are well within the range for similar benzimidazole
based salts [34,44,45].]. The bond angles between benzimi-
dazole ring and xylyl were found to be N2-C8-C9 = 111.92(13)o and N3-C13-C15 = 112.33(13)o from opposite direc-
tion. In the crystal, the hexaflourophosphate anions link
the cations with a three-dimensional network via the
intermolecular hydrogen bonding C-H. . ..F (2.547 and
2.560 Å). A perspective view of the salt and its crystal
packing are shown in Figure 8.
Salt Additional file 6: 10 crystallized in monoclinic
space group P-21/n with one cationic para-xylyl linked
bis-benzimidazolium core and two hexaflourophosphate
anions. Crystal studies reveal the existence of salt in a
zig-zag manner having benzimidazolium units almost
perpendicular to the plane of xylyl group. The internal
imidazole ring angle (N–C–N) at the carbene center is
110.64(8)° for N1-C1-N2 this value is well within the
range for similar benzimidazole based salts [34,44,45].
The bond angle between benzimidazolium components
and xylyl group was found to be N2-C11-C12 = 112.69
(8)o. In the crystal, the hexaflourophosphate anions link
the cations with a three-dimensional network via the
intermolecular hydrogen bonding C-H. . ..F (2.421 and
2.450 Å). A perspective view of the salt and its crystal
packing are shown in Figure 9.
Benzene rings of benzimidazolium and xylyl units
Interestingly, benzene rings of benzimidazolium and
xylyl units have uniquely different bond lengths and
angels. This might be due to different substitutions that
create different environment for each incorporated atom
in aromatic system. For example, benzene ring of benzi-
midazolium unit is not symmetric and is little bit com-
pressed. This might be due to electron withdrawing
effect of imidazolium cation. Figure 6 highlights the
bond angels 115.98o, 116.06o, & 117.36o in red. These
bond angels are 3o-5o lesser than the bond angels of
neighboring atoms within the same ring. However, this
difference is smaller for benzene rings of xylyl unit i.e.,
1o-2o. Also, the bond lengths of both types of benzenes
have the same story. This proves that two neighboring
aromatic systems with comparatively different ring sizes
affect the geometry of each other.
In vitro anticancer activity
In this study, antiproliferative potential of three newly
synthesized bis-benzimidazolium salts, with halide & PF6
counteranions (5-10) and their Ag(I)-NHC complexes
(11-13) were evaluated using MTT assay on human colo-
rectal cancer cells (HCT 116). The results were reported
as mean percentage inhibition of cell proliferation (±SD).
All the bis-benzimidazolium salts with bromide as coun-
teranions (5-7) were found to be relatively active (IC50 =
85, 0.2, & 157.52 μM for 5, 6, & 7 respectively) compare
to the same benzimidazolium salts with hexaflouropho-
sphate as counteranions (IC50 = > 200 μM for compounds
8-10). This is in accordance with our previous reports
Bond Angels Bond Lengths
Figure 6 A comparisons of bond angles and bond lengths for benzene rings of benzimidazolium and xylyl units in
bis-benzimidazolium salts (All the bond angles and bond lengths were selected from the crystallographic data of respective salt).
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pounds with these structures are relatively active compare
to the compounds with hexaflourophosphate as counter
anions. The counteranions of these salts are usually ex-
changed from halide to PF6 for the ease of handling and
in some cases to achieve the purity because these com-
pounds as PF6 salts appear as white powder whereas in
halide form these salts are mostly thick oily fluids before
recystalization. The silver complexes (11-13) showed rela-
tively better antiproliferation activity with IC50 (concentra-
tion of the test compound to achieve 50% inhibition)43, 44.5, and 9.7 μM for complexes 11, 12, and 13
respectively.
The pure metals are inactive; however, the activity of
metal cations varies on their bioavailability. Hence deliv-
ery methods, solubility, and ionization of the silver
sources are significant parameters to deal metals in bio-
logical systems [46]. Possibly this is the reason that the
bonding of silver cations to biologically compatible
ligands enhances the bioavailability and ultimately the
activity of silver cations. This is very obvious with our
current and previously reported results [25,26,30,47],
Figure 7 The ORTEP picture of bis-benzimidazolium salt 5.2Br with displacement ellipsoids drawn at 50% probability and crystal
packing (Monoclinic).
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http://journal.chemistrycentral.com/content/7/1/27where ligands were found to be relatively less active
compare to respective silver complexes. The photo-
micrograph of the cells treated with the silver com-
plexes revealed the morphological features of apoptosis
consist of membrane blebbing, nuclear condensation
and formation of apoptotic bodies (Figure 10). It is
reported that silver-N-heterocyclic carbene complexes
induce caspase independent apoptosis via mitochon-
drial apoptosis-inducing factor [9]. Several studiesshowed that silver cations bind to the cell surfaces and
interact with the enzymes and proteins that are import-
ant for the cell wall synthesis [19,26,46], this property of
silver was confirmed in the photomicrographs of cells
treated with the silver complexes where the silver de-
position can be clearly visualized in the membrane as
well as around the cellular organelles (Figure 10). The
variation in N-alkyl chain length might further affect
the potency of these compounds as the substituent
Figure 8 The ORTEP picture of bis-benzimidazolium salt 9.2PF6 with displacement ellipsoids drawn at 50% probability and crystal
packing (Monoclinic).
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http://journal.chemistrycentral.com/content/7/1/27produces variation in the lipophilicity of the drugs
[26,28]. Thus, the antiproliferative effect of tested com-
plexes is likely due to the lipophilicity of the complexes
that alleviates the transport of silver complexes into the
cell and posteriorly into the organelles where silver may
possibly contribute to toxicity by inhibiting cellular res-
piration and metabolism of biomolecules. Figure 11
shows the dose dependent antiproliferative effect of
synthetic complexes (11-13) whereas the ligands (8-10)
having PF6 counteranions were found inactive and the
ligands (5-7) having bromide counteranions showed
mild cytotoxicity; hence dose dependent charts for these
compounds were not included.
From our previous studies we have noticed an interest-
ing phenomenon with respect to the n-alkyl N-substitutions in benzimidazole ring where the activity of
silver complexes increased with increasing the chain
length [26,28]. However, in the present work the experi-
mental data for iso-propyl substituted compounds
reflects that the compounds are not as potential as with
n-alkyl substitutions. Also, recently we reported imid-
azole based similar ortho-, meta-, and para-xylyl linked
salts and respective Ag(1)-NHC complexes with in vitro
anticancer activity against the same cell line (HCT 116),
where we found that the allyl-substituted para-xylyl
linked dinuclear Ag(I)-NHC complex the demonstrated
higher cytotoxicity with IC50 0.9 μM [30]. Consistently,
in the present work the benzimidazole based para-xylyl
linked iso-propyl-substituted complex (13) demonstrated
higher cytotoxicity with IC50 9.7 μM, whereas the ortho-
Figure 9 The ORTEP picture of bis-benzimidazolium salt 10.2PF6 with displacement ellipsoids drawn at 50% probability and crystal
packing (Monoclinic).
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http://journal.chemistrycentral.com/content/7/1/27as well as meta- xylyl linked complexes (11 and 12)
demonstrated comparatively moderate activities. This
activity could be attributed to the cavity and size of the
molecule. The molecules with para substitution assume
bigger cavity and larger size compared to the ortho and
meta units which increases the exposure of N-heterocyc-
lic carbene (NHC) rings. Moreover, from the present
work it is observed that the isopropyl substitution did
not show improved activity than compared to the n-
alkyl substitution. The most probable reason could be
the symmetry of the molecule. The more symmetric the
molecule is the lesser the cytotoxicity [29]. The results
showed that the chain length regulates the symmetry of
the molecule, the longer the chain length, the lesser the
symmetry. Further studies are under investigation to
understand the differential efficacies of the compounds.Conclusions
In conclusion, Ag(I)-NHC complexes were found rela-
tively active compared to the respective ligands indicating
that silver cations play a vital role against cancer cells. The
higher cytotoxic effect of Ag(I)-NHC complexes might be
due to the deposition of silver cations in the membrane of
cells and the organelles and thus, possibly causing the tox-
icity by interfering with cellular respiration and metabol-
ism of biomolecules. The microscopic results revealed
that, the toxicity induced by the silver complexes might be
via apoptosis pathway, as induction of membrane bleb-
bing, chromatin condensation and formation of apoptotic
bodies was observed. The findings of the present work
conclude that the para-xylyl linked compounds are more
active compared to the complexes with ortho- and meta-
compartments. In addition, the iso-propyl N-substituted
Figure 10 HCT116 cell images were taken under an inverted phase-contrast microscope at × 200 magnification with a digital camera
at 48 h after treatment with the samples. A) Cells from the control group showed fully confluent growth with compactly proliferating HCT
116 cells. Treatment with 8 (B), 9 (C) and 10 (D) showed negligible cytotoxicity, as the cell growth did not get affected and cellular morphology
was similar to that of negative control. E) Photomicrograph depicts the strong cytotoxic effect of 5-fluorouracil (IC50 = 5.9 μM). It can be seen
clearly that the compound affected the normal morphology of all most all the cells of the group which rendered the cells to lose their viability.
Except few affected cells, only the cellular debris remained can be seen in the growth medium. F) Treatment with 11 showed significant
inhibition in HCT 116 cell proliferation with IC50 = 43 μM, as the population of cells reduced drastically within the 48 h of treatment. The picture
revealed that, the treated cells exhibited apoptotic cellular death, which is evident through the appearance of membrane blebbing, nuclear
condensation and apoptotic bodies. G) HCT 116 cells treated with the compound 12 exhibited considerable cytotoxicity (IC50 = 44.5 μM). As the
photomicrograph depicts the treatment of HCT 116 cells with the compound showed significant inhibitory effect on the cellular growth as
compared to the untreated cells. H) Cells treated with the 13 (IC50 = 9.7 μM) showed most potent cytotoxicity among all the tested samples. The
activity is comparable to that of standard reference, 5-fluorouracil. The viability of the cells was severely affected, as the photomicrograph showed
all the treated cells lost their viable characteristic features.
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Nuclear magnetic resonance spectra were recorded on
Bruker 500 MHz Ultrashield™ spectrometers at ambient
temperature. 1H and 13C NMR peaks are labelled as
singlet (s), doublet (d), triplet (t), quartet (q), pentet
(pent), sextet (sext), septet (sept) and multiplet (m),
Chemical shifts were referenced with respect to solvent
signals. Elemental analysis was carried out on a Perkin
Elmer series II, 2400 microanalyzer. X-ray diffraction
data were taken with Bruker SMART APEX2 CCD area-
detector diffractometer available. The melting and boil-
ing points were assessed by using a Stuart Scientific
SMP-1 (UK) instrument. Chemicals and solvents were
used as received without further purifications.
RPMI 1640 was purchased from ScienCell, USA. Tryp-
sin and heat inactivated foetal bovine serum (HIFBS)
were obtained from GIBCO, UK. Phosphate buffered sa-
line (PBS), penicillin/streptomycin (PS) solution, MTT
reagent and 5- fluorouracil were purchased from Sigma-
Aldrich, Germany. All other chemicals used in this study
were analytical grade or better.
Syntheses
Synthesis of N-substituted bis-benzimidazolium salts (5-10)
Synthesis of 3,3'-[(1,2-phenylenebis(methylene)]bis(1-ipropyl-
benzimidazolium) bis-hexaflourophosphate(5/8)
N-ipropyl benzimidazole (3.20 g, 0.02 mol) was added
drop wise in a vigorously stirring solution of 1,2-Figure 11 Anti-proliferation effect of test compounds on HCT 116 wa
of test complexes (11-13). The activity of silver complexes was found signif
were less profound than 5-FU (values are represented as mean ± SD n=3).dibromomethyl benzene (2.36 g, 0.01 mol) in 40 ml of
1,4-dioxane and refluxed for 24 h. The product appeared
as powderous material in reaction medium, filtered,
washed by fresh dioxane (3 × 5 mL), and dried at room
temperature for 24 h. General reaction involved in the
preparation of N-alkyl substituted bis-benzimidazolium
salts is shown in Scheme 1. Single crystals suitable for x-
ray diffraction study were obtained by slow evaporation
of saturated solution of title compound in methanol/
water (3:1) at room temperature.
Colorless plates. Yield 5.13g (88.14%), mp: 266-268°C.
1H NMR (500 MHz, d6-DMSO): 1.68 (12H, d, 4 × CH3,
J = 6.5 Hz), 5.15 (2H, spet., 2 × N-CH), 6.19 (4H, s, 2 ×
N-CH2-Ar), 7.13 (2H, q, Ar 2 × CH, J = 3.5 Hz), 7.36
(2H, q, Ar 2 × CH, J = 3.5 Hz), 7.65 (2H, t, Ar 2 × CH,
J = 7.5 Hz), 7.71 (2H, t, Ar 2 × CH, J = 7.5 Hz), 7.98
(2H, d, Ar 2 × CH, J = 8.5 Hz), 8.24 (2H, d, Ar 2 × CH,
J = 8.0 Hz), 10.28 (2H, s, 2 × NCHN); 13C{1H}NMR(125
MHz, d6-DMSO): 21.4 (2 × CH3), 47.7 (2 × N-CH), 51.0
(Ar-CH2-N), 114.3 (Ar-C, d, J = 13.7 Hz), 126.7 (Ar-C,
d, J = 6.2 Hz), 127.9, 128.9, 130.6, 131.3, 132.0 (Ar-C)
and 141.5 (NCHN). FT-IR (KBr): υ (cm-1); 3479, 3423,
3377 (Caliph-Nbenzimi); 3242, 3125 (C-Harom); 3033, 2972
(C-Haliph), 1625, 1607, 1559 (Carom-Carom); 1481, 1457,
1430, 1396, 1374 (Carom-Nbenzimi). Anal. Cal. For:
C28H32Br2N4: C, 57.55; H, 5.52; N, 9.95%. Found: C,
58.10; H, 5.66; N, 9.80%. Analytical and spectral results
of 8.PF6 salt were found comparable with its structure.
Synthesis of 3,3'-[(1,3-phenylenebis(methylene)]bis(1-ipropyl-
benzimidazolium) bis-hexaflourophosphate (6/9)
Compound 6 was prepared according to the same proced-
ure for 5; N-ipropyl benzimidazole (3.20 g, 0.02 mol) and
1,4-dibromomethyl benzene (2.36 g, 0.01 mol). Singles assessed by MTT-assay. The figure depicts dose-dependent activity
icant compare to respective salts however all the synthesized drugs
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by slow evaporation of saturated solution of title com-
pound in methanol/water (3:1) at room temperature.
White powder. Yield 3.81 g (65.46%), mp: 118-120ºC.
1H NMR (500 MHz, d4-methanol): 0.46 (12H, d, 4 ×
CH3, J = 7.0 Hz), 3.79 (2H, spet., 2 × N-CH), 4.52 (4H, s,
2 × N-CH2-Ar), 6.17-6.23 (3H, m, Ar 3 × CH), 6.28 (1H,
d, Ar 1 × CH, J = 7.5 Hz), 6.36 (2H, t, Ar 2 × CH, J =
8.0 Hz), 6.42 (1H, d, Ar 1 × CH, J = 8.5 Hz), 6.51 (1H, s,
Ar 1 × CH), 6.74 (2H, d, Ar 2 × CH, J = 8.5 Hz), 8.69
(2H, s, 2 × NCHN); 13C{1H} NMR (125 MHz, d4-
methanol): 22.4 (2 × CH3), 51.8 (2 × N-CH), 53.1 (Ar-
CH2-N), 115.3 (Ar-C, d, J = 11.2 Hz), 128.4 (Ar-C, d, J =
8.7 Hz), 129.4, 130.2, 131.4, 132.9, 136.2 (Ar-C) and
141.7 (NCHN). FT-IR (KBr): υ (cm-1); 3498, 3398 (Caliph-
Nbenzimi); 3160, 3060 (C-Harom); 2982, 2938 (C-Haliph),
1654, 1610, 1563 (Carom-Carom); 1478, 1431, 1494, 1394,
1340 (Carom-Nbenzimi Anal. Cal. For: C28H32Br2N4: C,
57.55; H, 5.52; N, 9.95%. Found: C, 58.10; H, 5.66; N,
9.80%. Analytical and spectral results of 9.PF6 salt were
found comparable with its structure.
Synthesis of 3,3'-[(1,4-phenylenebis(methylene)]bis(1-ipropyl-
benzimidazolium) bis- hexaflourophosphate (7/10)
Compound 7 was prepared according to the same pro-
cedure for 5; N-ipropyl benzimidazole (3.20 g, 0.02 mol)
and 1,4-dibromomethyl benzene (2.36 g, 0.01 mol).
White crystalline powder. Yield 4.92 g (84.53%), mp:
262-264oC. 1H NMR (500 MHz, d4-methanol): 1.80
(12H, d, 4 × CH3, J = 6.5 Hz), 5.15 (2H, spet., 2 × N-CH),
5.86 (4H, s, 2 × N-CH2-Ar), 7.62-7.65 (6H, t, Ar-CH),
7.71 (2H, t, Ar 2 × CH, J = 8.5 Hz), 7.85 (2H, d, Ar 2 × CH,
J = 8.5 Hz), 8.09 (2H, d, Ar 2 × CH, J = 8.0 Hz), 10.00
(2H, s, 2 × NCHN); 13C{1H} NMR (125 MHz, d4-metha-
nol): 22.3 (2 × CH3), 51.6 (2 × N-CH), 53.0 (Ar-CH2-N),
115.2 (Ar-C, d, J = 13.7 Hz), 128.4 (Ar-C, d, J = 12.5 Hz),
130.2, 132.6, 132.9, 135.9 (Ar-C) and 141.5 (NCHN). FT-IR
(KBr): υ (cm-1); 3441, 3388 (Caliph-Nbenzimi); 3118, 3019
(C-Harom); 2974, 2928 (C-Haliph); 1613, 1557 (C-Haliph);
1487, 1427, 1373, 1318 (Carom-Nbenzimi Anal. Cal. For:
C28H32Br2N4: C, 57.55; H, 5.52; N, 9.95%. Found: C, 57.63;
H, 5.66; N, 9.80%. Analytical and spectral results of 10.PF6
salt were found comparable with its structure.
Synthesis of Ag-NHC Complexes (11-13)
Synthesis of 3,3'-[1,2-phenylenebis(methylene)]bis(1-ipropyl-
benzimidazolium) disilver (I) bis(hexaflourophosphate) (11)
Compound 5 (1.68 g, 0.002 mol) was dissolved in
methanol (100 mL) alongwith Ag2O (0.7 g, 0.003 mol)
with excluion of light by enveloping flask with aliminum
foil. The reaction mixture was stirred for a period of 2
days at room temperature, filtered by celites 545, to col-
lect a crystal clear solution. So obtained was stirred with
potassium hexaflourophosphate (0.87 g, 0.003 mol). Titlecompound appeared as white powder in methaol, fil-
tered by whatman filter paper, washed by distilled water
(3 × 5 mL) following by methanol (3 × 5 mL). Dried
under vaccum for 24 h. Synthesis of benzimidazole
based Ag-NHC complexes is shown in Sheme 2.
White powder. Yield 1.10g (81.48%), mp 240-242oC.
1H NMR (500 MHz, d3-acetonitrile): 1.54 (24H, d, 8 ×
CH3, J = 7.0 Hz), 4.94 (4H, spet., 2 × N-CH), 5.64 (8H, s,
2 × N-CH2-Ar), 7.10 (4H, q, Ar 4 × CH, J = 3.5 Hz), 7.26
(4H, q, Ar 2 × CH, J = 3.5 Hz), 7.39 (4H, t, Ar 4 × CH, J =
8.0 Hz), 7.45-7.51 (8H, m, Ar 8 × CH), 7.83 (4H, d, Ar 2 ×
CH, J = 8.0 Hz); 13C{1H} NMR (125 MHz, d3-acetonitrile):
23.0 (4 × CH3), 51.9 (4 × N-CH), 54.2 (Ar-CH2-N), 114.0
(Ar-C, d, J = 85.0 Hz), 125.6 (Ar-C, d, J = 22.5 Hz), 130.3
(Ar-C, d, J = 18.7 Hz), 134.0, 124.8 (Ar-C) and 188 [d,
1J (C-109Ag) = 208 Hz] & [d,
1J (C-107Ag) = 184 Hz]. FT-IR
(KBr): υ (cm-1); 3426 (Caliph-Nbenzimi); 3156, 3060 (C-Harom);
2979, 2939, 2880 (C-Haliph), 1607, 1560 (Carom-Carom); 1477,
1442, 1411, 1393, 1373, 1341 (Carom-Nbenzimi). Anal. Cal.
For: C56H60Ag2F12N8P2: C, 49.79; H, 4.48; N, 8.30%. Found:
C, 49.50; H, 4.66; N, 8.45%.
Synthesis of 3,3'-[1,3-phenylenebis(methylene)]bis(1-ipropyl-
benzimidazolium) disilver (I) bis(hexaflourophosphate) (12)
Compound 12 was synthesized by following the same
procedure for 8; Compound 6 (1.23 g, 0.002 mol) and
Ag2O (0.7 g, 0.003 mol).
White powder. Yield 0.87g (64.44%), mp: 242-244°C. 1H
NMR (500 MHz, d6-DMSO): 0.48 (24H, d, 8 × CH3, J = 7.0
Hz), 3.52 (4H, spet., 4 × N-CH), 5.13 (8H, s, 4 × N-CH2-
Ar), 6.17-6.23 (6H, m, Ar 3 × CH), 6.59 (2H, d, Ar 1 × CH,
J = 7.5 Hz), 6.39 (4H, t, Ar 2 × CH, J = 8.5 Hz), 6.44
(2H, d, Ar 1 × CH, J = 8.5 Hz), 6.55 (1H, s, Ar 1 × CH),
6.78 (4H, d, Ar 2 × CH, J = 8.5 Hz); 13C{1H} NMR (125
MHz, d6-DMSO): 24.7 (4 × CH3), 52.7 (4 × N-CH), 54.2
(Ar-CH2-N), 115.3 (Ar-C, d, J = 13.7 Hz), 128.3 (Ar-C, d,
J = 8.7 Hz), 129.6, 130.5, 131.7, 132.6, 136.2 (Ar-C) and
188 [d, 1J (C-109Ag) = 208 Hz] & [d,
1J (C-107Ag) = 181 Hz].
FT-IR (KBr): υ (cm-1); 3396 (Caliph-Nbenzimi); 3119, 3031
(C-Harom); 2979, 2929 (C-Haliph), 1654, 1610, 1563
(Carom-Carom); 1478, 1431, 1394, 1340 (Carom-Nbenzimi
Anal. Cal. For: C56H60Ag2F12N8P2: C, 49.79; H, 4.48; N,
8.30%. Found: C, 49.55; H, 4.64; N, 8.47%.
Synthesis of 3,3'-[1,4-phenylenebis(methylene)]bis(1-ipropyl-
benzimidazolium) disilver (I) bis(hexaflourophosphate) (13)
Compound 13 was synthesized by following the same
procedure for 8; Compound 7 (1.23 g, 0.002 mol) and
Ag2O (0.7 g, 0.003 mol).
Beige colored powder. Yield 1.18 g (87.04%), mp: 320-
322oC. 1H NMR (500 MHz, d6-DMSO): 1.80 (24H, d,
8 × CH3, J = 7.0 Hz), 5.42 (4H, spet., 4 × N-CH), 5.60
(8H, s, 4 × N-CH2-Ar), 7.11 (8H, s, Ar-CH), 7.32 (6H,
t, Ar-CH), 7.44 (4H, m, Ar-CH), 7.80 (4H, d, Ar 4 × CH,
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(4 × CH3), 53.4 (4 × N-CH), 53.8 (Ar-CH2-N), 113.8
(Ar-C, d, J = 92.5 Hz), 125.4 (Ar-C, d, J = 22.5 Hz), 128.2,
134.0, 134.8, 137.0 (Ar-C) and 189 [d, 1J (C-109Ag) = 209 Hz]
& [d, 1J (C-107Ag) = 183 Hz]. FT-IR (KBr): υ (cm
-1); 3430
(Caliph-Nbenzimi); 3109, 3060 (C-Harom); 2976, 2933,
2881 (C-Haliph); 1611, 1518 (C-Haliph); 1477, 1439,
1424, 1395, 1355, 1341 (Carom-Nbenzimi). Anal. Cal. For:
C56H60Ag2F12N8P2: C, 49.79; H, 4.48; N, 8.30%. Found:
C, 49.63; H, 4.68; N, 8.39%.
In vitro anticancer activity
Preparation of cell culture
Initially, HCT 116 cells were allowed to grow under op-
timal incubator conditions. Cells that had reached a con-
fluence of 70-80% were chosen for cell plating purposes.
Old medium was aspirated out of the plate. Next, cells
were washed using sterile phosphate buffered saline
(PBS) (pH 7.4), 2-3 times. PBS was completely discarded
after washing. Following this, trypsin was added and dis-
tributed evenly onto cell surfaces. Cells were incubated
at 37°C in 5% CO2 for 1 min. Then, the flasks containing
the cells were gently tapped to aid cells segregation and
observed under inverted microscope (if cells segregation
is not satisfying, the cells will be incubated for another
minute) Trypsin activity was inhibited by adding 5 ml of
fresh complete media (10% FBS). Cells were counted
and diluted to get a final concentration of 2.5 × 105 cells/
mL, and inoculated into wells (100 μL cells/well). Finally,
plates containing the cells were incubated at 37°C with
an internal atmosphere of 5% CO2.
MTT assay
Cancer cells (100 μL cells/well, 1.5 × 105 cells/mL) were
inoculated in wells of microtitre plate. Then the plate was
incubated overnight in CO2 incubator in order to allow the
cell for attachment. 100 μL of test substance were added
into each well containing the cells. Test substance was
diluted with media into the desired concentrations from
the stock. The plates were incubated at 37°C with an in-
ternal atmosphere of 5% CO2. After 72 h treatment period,
20 μL of MTT reagent was added into each well and incu-
bated again for 4 h. After this incubation period, 50 μL of
MTT lysis solution (DMSO) was added into each well. The
plates were further incubated for 5 min in CO2 incubator.
Finally, plates were read at 570 and 620 nm wavelengths
using a standard ELISA microplate reader. Data were
recorded and analyzed for the assessment of the effects of
test substance on cell viability and growth inhibition. The
percentage of growth inhibition was calculated from the
optical density (OD) that was obtained from MTT assay. 5-
FU was used as the standard reference drug.Additional files
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